Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Pillai

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Oral Diseases|November 5, 2005
Human papillomavirus and disease mechanisms: relevance to oral and cervical cancersS Nair, M R Pillai
Experimental and Molecular Pathology|December 15, 2000
Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumorsM R Pillai, M K Nair
Nuclear Medicine Communications|September 16, 2017
Rhenium-188 as a therapeutic radionuclide in low-income and middle-income countriesAjit Shinto, Ambi M R Pillai
Journal of Oral Pathology|September 1, 1987
Immunology of premalignant and malignant conditions of the oral cavity. II. Circulating immune complexesP Balaram, M R Pillai, T Abraham
Seminars in Nuclear Medicine|November 17, 2001
Evolution of Tc-99m in diagnostic radiopharmaceuticalsS Banerjee, M R Pillai, N Ramamoorthy
Singapore Dental Journal|August 1, 1997
Chemoprevention of oral cancer: the need for effective biological monitoringM R Pillai, D Ravi, M K Nair
Current Radiopharmaceuticals|March 16, 2015
Evolving Important Role of Lutetium-177 for Therapeutic Nuclear MedicineAmbikalmajan M R Pillai, Furn F Russ Knapp
Indian Journal of Biochemistry & Biophysics|August 1, 1997
Characteristics of a 60K gelatinase involved in rat mammary gland involutionM Ambili, M R Pillai, P R Sudhakaran
Journal of Surgical Oncology|March 1, 1993
Oral cancer and human papillomaviruses: is there a link?S Lakshmi, S A Nair, M R Pillai
Current Radiopharmaceuticals|December 15, 2015
Lutetium-177 Labeled Therapeutics: ¹⁷⁷Lu-PSMA is Set to Redefine Prostate Cancer TreatmentAmbikalmajan M R Pillai, Furn F Russ Knapp
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Oral Diseases|November 5, 2005
Human papillomavirus and disease mechanisms: relevance to oral and cervical cancersS Nair, M R Pillai
Experimental and Molecular Pathology|December 15, 2000
Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumorsM R Pillai, M K Nair
Nuclear Medicine Communications|September 16, 2017
Rhenium-188 as a therapeutic radionuclide in low-income and middle-income countriesAjit Shinto, Ambi M R Pillai
Journal of Oral Pathology|September 1, 1987
Immunology of premalignant and malignant conditions of the oral cavity. II. Circulating immune complexesP Balaram, M R Pillai, T Abraham
Seminars in Nuclear Medicine|November 17, 2001
Evolution of Tc-99m in diagnostic radiopharmaceuticalsS Banerjee, M R Pillai, N Ramamoorthy
Singapore Dental Journal|August 1, 1997
Chemoprevention of oral cancer: the need for effective biological monitoringM R Pillai, D Ravi, M K Nair
Current Radiopharmaceuticals|March 16, 2015
Evolving Important Role of Lutetium-177 for Therapeutic Nuclear MedicineAmbikalmajan M R Pillai, Furn F Russ Knapp
Indian Journal of Biochemistry & Biophysics|August 1, 1997
Characteristics of a 60K gelatinase involved in rat mammary gland involutionM Ambili, M R Pillai, P R Sudhakaran
Journal of Surgical Oncology|March 1, 1993
Oral cancer and human papillomaviruses: is there a link?S Lakshmi, S A Nair, M R Pillai
Current Radiopharmaceuticals|December 15, 2015
Lutetium-177 Labeled Therapeutics: ¹⁷⁷Lu-PSMA is Set to Redefine Prostate Cancer TreatmentAmbikalmajan M R Pillai, Furn F Russ Knapp
Pageof 10